Biofrontera AG American Depositary Shares
BFRA
BFRA was delisted on the 4th of March, 2022.
2 hedge funds and large institutions have $23K invested in Biofrontera AG American Depositary Shares in 2019 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.
60% less funds holding
Funds holding: 5 → 2 (-3)
99% less capital invested
Capital invested by funds: $2.06M → $23K (-$2.04M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$577 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
-$1.87M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$11K |
BFRA Hedge Fund Activity: Q2 2019 in Review
2 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Biofrontera AG American Depositary Shares (BFRA) for Q2 2019, worth a combined $23K — down 99% from $2.06M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of BFRA and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Tower Research Capital (TRC), adding an estimated $577. The largest seller was Heartland Advisors, exiting entirely with an estimated $1.87M sold.
- 2 institutional investors held Biofrontera AG American Depositary Shares (BFRA) as of Q2 2019, down from 5 in Q1 2019.
- Funds reported $23K of Biofrontera AG American Depositary Shares stock for Q2 2019, down 99% quarter-over-quarter.
- 0 funds opened new Biofrontera AG American Depositary Shares positions in Q2 2019 and 2 closed out, a net change of -2 holders.
- The largest Biofrontera AG American Depositary Shares buyer in Q2 2019 was Tower Research Capital (TRC), an estimated $577 added.
- The largest Biofrontera AG American Depositary Shares seller in Q2 2019 was Heartland Advisors, an estimated $1.87M sold.
Based on aggregated 13F filings for Q2 2019.